Influenza Educational Initiative HOME     |     CME     |     FEEDBACK












Presented by The Johns Hopkins University School of Medicine

Made possible by an independent educational grant from Roche

In collaboration with Gullapalli & Associates, LLC

 
Council

CO-COURSE DIRECTORS

1. John G. Bartlett, MD: Professor of Medicine, Division of Infectious Diseases, the Johns Hopkins University School of Medicine
2. Trish M. Perl, MD, MSc: Professor, Department of Medicine, Division of Infectious Diseases, Johns Hopkins University
3. Thomas C. Quinn, MD, MSc: Director, Johns Hopkins Center for Global Health; Professor of Medicine, Division of Infectious Diseases, the John Hopkins University

FACULTY PARTICIPANTS

1. Suzanne F. Bradley, MD: Associate Professor of Internal Medicine, Divisions of Geriatric Medicine & Infectious Diseases, University of Michigan Medical School
2. Jeffrey S. Duchin, MD, FACP, FIDSA: Chief, Communicable Disease Control, Epidemiology & Immunization Section, Public Health, Seattle & King County; Associate Professor in Medicine, Division of Allergy & Infectious Diseases, Adjunct Associate Professor, School of Public Health and Community Medicine, University of Washington
3. William Glezen, MD: Professor, Department of Molecular Virology and Microbiology and Professor and Head, Preventive Medicine Section, Department of Pediatrics at Baylor College of Medicine, Adjunct Professor of Epidemiology, School of Public Health, University of Texas Health Science Center, Houston
4. Thomas Inglesby, MD: Chief Operating Officer and Deputy Director, Center for Biosecurity
5. Donald E. Low, MD, FRCPC: Professor, University of Toronto, Microbiologist-in-Chief, Department of Microbiology, Mount Sinai Hospital; Medical Director, Ontario Public Health Laboratories.
6. Kristin Nichol, MD, MPH, MBA: Professor of Medicine, University of Minnesota; Chief of Medicine, Minneapolis VA Medical Center
7. Kenneth E. Sands, MD, MPH: Senior Vice President and Medical Director of Health Care Quality at Beth Israel Deaconess Medical Center, Assistant Professor of Medicine, Harvard Medical School
8. Thomas R. Talbot, MD, MPH: Assistant professor of Medicine and Preventive Medicine at Vanderbilt University School of Medicine; Chief Hospital Epidemiologist at Vanderbilt Medical Center


John G. Bartlett, MD

John G. Bartlett, MD, is a professor of medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine in Baltimore.  He served as chief of the Infectious Disease Division at the School for 26 years, stepping down in June 2006.  Dr. Bartlett received his undergraduate degree at Dartmouth College, Hanover, New Hampshire, and his MD at Upstate Medical Center, Syracuse, New York. He trained in internal medicine at the Peter Bent Brigham Hospital, Boston and the University of Alabama, Birmingham, and he completed his fellowship training in infectious diseases at the University of California, Los Angeles (UCLA).

Before accepting his current position at Johns Hopkins, Dr. Bartlett served as a faculty member at UCLA and Tufts University School of Medicine in Boston and was associate chief of staff for research at the Boston VA Hospital.

Dr. Bartlett has worked in several areas of research, all related to his specialty in infectious diseases. His major research interests have included anaerobic infections, pathogenic mechanisms of Bacteroides fragilis, anaerobic pulmonary infections, and Clostridium difficile-associated colitis. Since moving to Johns Hopkins, his major interests have been HIV/AIDS, managed care of patients with HIV infection, and bioterrorism.

Dr. Bartlett is a member of the Institute of Medicine, a master of the American College of Physicians, past president of the Infectious Diseases Society of America (IDSA), and a recipient of the Kass Award from the IDSA. In 2005, Dr. Bartlett was awarded the Alexander Fleming Award by the IDSA and the Finland Award from the National Foundation for Infectious Diseases (NFID).

Dr. Bartlett has authored over 500 articles and reviews, more than 280 book chapters, and over 60 editions of 18 books. He has served on editorial boards for 19 medical journals.

 

back to top


Trish Perl, MD, MSc

Trish Perl, MD, MSc, is a professor in the Department of Medicine, Infectious Diseases at the Johns Hopkins University School of Medicine, and in the Department of Epidemiology at the Bloomberg School of Hygiene at Johns Hopkins University in Baltimore. She is also director of hospital epidemiology and infection control and hospital epidemiologist at the Johns Hopkins Hospital.

She earned her BA and MD from the University of North Carolina at Chapel Hill in Chapel Hill, North Carolina. Dr. Perl earned a master’s degree in science and completed her internship, residency, and fellowship in internal medicine at McGill University in Montreal, Canada. She completed a fellowship in infectious diseases and clinical epidemiology at the University of Iowa Hospitals and Clinics in Iowa City, Iowa.

Dr. Perl is the 2006 president of the Society for Healthcare Epidemiology of America and has served as the chair of the annual meeting planning committee and on its nominations and bioterrorism committees.  She is a member of the American College of Physicians, American Society of Microbiology, American Federation for Clinical Research, and the Infectious Diseases Society of America. She serves on the annual planning committee of the Association of Practitioners of Infection Control. Dr. Perl has served on advisory panels for the Centers for Disease Control and Prevention and has been a consultant to the National Institutes of Health and the Agency for Healthcare Research and Quality. She is on the editorial board of the American Journal of Infection Control and is a reviewer for Infection Control and Hospital Epidemiology, Journal of the American Medical Association, and the New England Journal of Medicine.

An active researcher, Dr. Perl has been a principal and co-principal investigator for studies on healthcare-associated infections, antimicrobial resistance and novel surveillance strategies for the Centers for Disease Control and Prevention. She has authored or coauthored more than 75 peer-reviewed articles for numerous journals and has written multiple chapters and contributed to guidelines and policies relevant to healthcare-associated infections.

Her scientific interests encompass Avian Flu, Clostridium difficile, MRSA, resistant gram-negative rods, surgical site infections, catheter-associated bloodstream infections, emerging infection prevention and interventions to prevent healthcare-associated infections, bioterrorism and pandemic preparedness, and patient and healthcare worker safety.

 

back to top


Thomas C. Quinn, MD, MSc

Thomas C. Quinn, MD, MSc, is associate director for international research of the Intramural Research Program and Senior Investigator in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases.  Since 1981, he has been assigned to the Johns Hopkins University School of Medicine, where he is a professor of medicine and deputy director of the Division of Infectious Diseases.  He also has adjunct appointments in the Departments of International Health, Epidemiology, and Molecular Microbiology and Immunology in The Johns Hopkins Bloomberg School of Public Health. In 2006, he was appointed director of the Center for Global Health at Johns Hopkins University. He currently directs the Johns Hopkins University School of Medicine P3 HIV/AIDS Research Facility and the International STD Research Laboratory.

Dr. Quinn's investigations have involved the study of the epidemiologic, virologic, immunologic features of HIV infection in Africa, the Caribbean, South America, and Asia.  In 1984, he helped establish the interagency project called "Project SIDA" in Kinshasa, Zaire, which was the largest AIDS investigative project in sub-Saharan Africa.  Dr. Quinn has been involved in laboratory investigations that have helped define the biological factors involved in heterosexual transmission and perinatal transmission, the natural history of HIV infections in developing countries, and the identification and characterization of unique strains of HIV-1 infection.  Immunologic studies have included the changes in T-cell phenotypes and cytokines in patients with HIV infection and other endemic tropical diseases such as malaria and tuberculosis. Dr. Quinn has been involved in HIV clinical and epidemiologic investigations in 25 countries, with current projects in Uganda, South Africa, Zimbabwe, Democratic Republic of the Congo, Tanzania, Ethiopia, Russia, India, China, Thailand, Peru, and Brazil.

Among his professional activities, Dr. Quinn is a member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been an advisor/consultant on HIV and STDs to the World Health Organization, UNAIDS, and the US Food and Drug Administration.  In October 2004, he received membership in the Institute of Medicine of the National Academy of Science.  He is a fellow of the Infectious Disease Society of America, a member of the American Association of Physicians, and the American Society for Clinical Investigation.  He is the recipient of multiple awards and honors and is an author of more than 700 publications on HIV, STDs, and infectious diseases.

 

back to top


Suzanne F. Bradley, MD

Suzanne F. Bradley, MD, is an associate professor of internal medicine in infectious diseases and geriatric medicine at the University of Michigan in Ann Arbor, Michigan, and a staff physician, Veterans Affairs at Ann Arbor Healthcare System, in Ann Arbor Michigan.  She received her AB magna cum laude in Biology from Mount Holyoke College in Holyoke, Massachusetts and her MD from SUNY Buffalo.  She completed an internal medicine residency at Ohio State University Hospital and fellowships in infectious diseases and geriatric medicine at the University of Michigan. She is board-certified in internal medicine and infectious diseases.

Dr. Bradley is a fellow of the Infectious Diseases Society of America (IDSA), the American College of Physicians, and the Society for Healthcare Epidemiology of America.  She has been involved in the development of infection control guidelines for nursing homes for the American Geriatrics Society (AGS), IDSA, and SHEA.  She has served as an expert reviewer for HICPAC and is a member of the Office of the Medical Inspector Veterans Health Administration Nursing Home Infection Surveillance Taskforce.  She is currently the Biosciences Section Editor for the AGS journal.  Her research has focused on the epidemiology and prevention of infection in nursing homes.

 

back to top


Jeffrey Scott Duchin, MD, FACP, FIDSA

Jeffrey Scott Duchin, MD, FACP, FIDSA, is chief of the Communicable Disease Control, Epidemiology & Immunization Section for Public Health in Seattle and associate professor of Medicine, Division of Infectious Diseases at the University of Washington in Seattle.  Dr. Duchin is board certified in internal medicine and infectious diseases and holds appointments as adjunct associate professor in the schools of Public Health and Community Medicine and Health Services, and Faculty, Northwest Center for Public Health Practice.  He is also the director of emergency response for the WAMI Regional Center of Excellence (RCE) in Biodefense and Emerging Infectious Disease Research.  Dr. Duchin has been elected to fellowship in the American College of Physicians and the Infectious Disease Society of America in recognition of his professional accomplishments.

Dr. Duchin is a graduate of the Centers for Disease Control and Prevention’s (CDC) Epidemic Intelligence Service and worked for CDC as a medical epidemiologist before assuming his current position. While at CDC he received the following awards and honors from the US Department of Health and Human Services’ Public Health Service: Outstanding Unit Citation for exemplary performance of duty; the Secretary’s Recognition Award for exceptional performance in the investigation of unexplained deaths associated with an outbreak of acute illness of unknown etiology in the Four Corners area of the southwestern United States (Hantavirus); the National Centers for Infectious Diseases Honor Award; and the United States Public Health Service Achievement Medal.  In 2004, Dr. Duchin was a member of a Department of Health and Human Services public health Tiger Team, consulting with the Government of Greece on health preparations for the 2004 Olympics in Athens, Greece.

Dr. Duchin sits on a number of local, state, and national committees, including the Bio-emergencies Work Group (which he chairs) and the Pandemic Influenza Work Group of the Infectious Disease Society of America.  He also works on immunization and pandemic influenza committees for the National Association of County and City Health Officials (NACCHO) and is NACCHO’s liaison to the CDC’s Advisory Committee on Immunization Practices.

Dr. Duchin’s peer-reviewed papers and research interests focus on communicable diseases of public health significance, and he has authored textbook chapters on the epidemiology of HIV/AIDS, bioterrorism, and outbreak investigations.

 

back to top


William Paul Glezen, MD

William Paul Glezen, MD, is professor, Department of Molecular Virology and Microbiology and professor and head, Preventive Medicine Section, Department of Pediatrics at Baylor College of Medicine in Houston.  He is also adjunct professor of epidemiology at the School of Public Health, University of Texas Health Science Center in Houston. He was recruited to join the Influenza Research Center at Baylor College of Medicine in 1975 as the epidemiologist.  He was a member of the Epidemiology and Disease Control study section, NIH, 1985-1989.  He served as a member of the Advisory Committee on Immunization Practices (ACIP) from 1987-1990, and was the liaison representative of the Infectious Diseases Society of America to the ACIP from 1993-1998.  He was a member of the Influenza Technical Advisory Group for the Medicare Demonstration Project, HCFA, from 1990-1993 and the Consultative Group for Vaccine Development, National Vaccine Program Office from 1991-1993.  He has been appointed to the Task Force on Adult and Maternal Immunization for the American College of Obstetricians and Gynecologists for 2005-2006. He has been the study chair for an NIAID research grant entitled “Control of Epidemic Influenza,” which is located in Central Texas.  Dr. Glezen received the 2004 Distinguished Physician Award from the Pediatric Infectious Diseases Society and the 2006 Distinguished Alumnus Award from the Purdue University College of Science in West Lafayette, Indiana.

 

back to top


Thomas Inglesby, MD

Dr. Inglesby is Chief Operating Officer and Deputy Director of the Center for Biosecurity of UPMC and Associate Professor of Medicine and Public Health at the University of Pittsburgh Schools of Medicine and Public Health. He is an infectious disease physician by training.

Dr. Inglesby is co-editor-in-chief of the peer-reviewed journal Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. He has authored a number of widely cited publications on anthrax, smallpox, plague, and biosecurity issues related to medicine and hospital preparedness, public health, science, pandemic planning, and national security. He is a principal editor of the Journal of the American Medical Association book Bioterrorism: Guidelines for Medical and Public Health Management.

Dr. Inglesby was a principal designer, author, and controller of the widely recognized Atlantic Storm exercise of 2005 and of the Dark Winter smallpox exercise of 2001.

He has served in advisory and consultative capacities for government, scientific organizations, and academia on issues related to biosecurity—providing briefings for officials in the Administration and for Congressional members and staff; serving on a task force of the Defense Science Board of the DoD and a committee of the National Research Council of the National Academies of Sciences; and participating in an advisory capacity to CDC, NIH, HHS, DHS, the Defense Advanced Research Projects Agency (DARPA), and the Defense Intelligence Agency (DIA). 

Prior to helping establish the Center for Biosecurity in 2003, Dr. Inglesby was one of the founding members of the Johns Hopkins Center for Civilian Biodefense Strategies, where he served as deputy director from 2001 to 2003. He was also a faculty member of the Johns Hopkins University School of Medicine from 1999 to 2003.

Dr. Inglesby is board-certified in Infectious Diseases. He received a BA from Georgetown University and an MD from the Columbia University College of Physicians and Surgeons. He completed his internal medicine residency and infectious diseases fellowship training at the Johns Hopkins University School of Medicine, and served as assistant chief of service in the Johns Hopkins Department of Medicine from 1996 to 1997.

 

back to top


Donald E. Low, MD, FRCPC

Donald E. Low, MD, FRCPC, is a fellow of the Royal College of Physicians and Surgeons of Canada.  He is a Fellow of the American Academy of Microbiology and a member of the Association of American Physicians.

Dr. Low's primary research interests are in the study of the epidemiology and the mechanisms of antimicrobial resistance in community and their clinical relevance.

A recognized authority in microbiology and infectious diseases, Dr. Low has published more than 300 papers in peer-reviewed journals.

Dr. Low is head of the Department of Microbiology at the Toronto Medical Laboratories and Mount Sinai Hospital in New York City.  He is a professor at the University of Toronto in the Department of Laboratory Medicine and Pathobiology and Department of Medicine.

 

back to top


Kristin Nichol, MD, MPH

Kristin Nichol, MD, MPH, is professor of medicine at the University of Minnesota and chief of medicine at the VA Medical Center in Minneapolis.  Dr. Nichol’s research has focused on issues relating to adults vaccines, with a special emphasis on influenza and pneumococcal vaccination.  She has pursued observational studies and clinical trials in such areas as successful delivery strategies, determinants of vaccination behavior, side effects associated with vaccination, and the clinical efficacy and cost effectiveness of vaccination. She has authored more than 100 publications in these areas. 

Dr. Nichol is chairperson of the National Coalition for Adult Immunization Advisory Committee and the Minnesota Coalition for Adult Immunization. She is also a member of the Minnesota Department of Health’s Immunization Practices Advisory Committee.  She serves as the Department of Veterans Affairs ex officio member of the US Advisory Committee on Immunization Practices.  

Dr. Nichol received her MD and MPH degrees from the University of Minnesota and her MBA from the University of St. Thomas.  She pursued her internal medicine training at the University of California, San Francisco and the University of Minnesota and is board-certified in internal medicine and preventive medicine.

 

back to top


Ken Sands, MD, MPH

Ken Sands, MD, MPH, is vice president and medical director of Healthcare Quality at Beth Israel Deaconess Medical Center in Boston. He is an assistant professor of Medicine at Harvard Medical School in Cambridge Massachusetts.  He earned his MD from Dartmouth Medical School in Hanover, New Hampshire in 1987, and a Master’s in Public Health from Harvard in 1993.   He joined the Infectious Disease division at Beth Israel Hospital in 1993 and was the Hospital Epidemiologist there until 1999, when he assumed his current role.

Dr. Sands has a continued research interest in patient safety and complications of hospitalization, with particular interest in surveillance methodologies for nosocomial infections.  More recent interests have been the detection and prevention of noninfectious healthcare-related adverse events, healthcare systems improvement, and performance improvement education of physician trainees. 

 

back to top


Thomas R. Talbot, MD, MPH

Thomas R. Talbot, MD, MPH, is an assistant professor of medicine and preventive medicine at Vanderbilt University School of Medicine in Nashville and also serves as the chief hospital epidemiologist for Vanderbilt University Medical Center.  He graduated from Duke University in 1992 and Vanderbilt University School of Medicine in 1996, where he was elected to Alpha Omega Alpha honor society.  He completed his residency in internal medicine at Johns Hopkins in 1999 and then returned in 2000 to serve as an assistant chief of service on the Osler Medical Service.  He completed his training in Infectious Diseases at Vanderbilt in 2003.

Dr. Talbot’s clinical research has focuses in the area of healthcare epidemiology and infection control.  He has a particular interest in the risk of secondary transmission from live vaccines, influenza vaccination of healthcare workers, and the prevention of nosocomial infections, particularly surgical site infections.  He is the author, along with Allen Kaiser, MD, of the chapter on antibiotic prophylaxis and surgical site infections for the current edition of Mandell, Bennett, and Dolin’s Principles and Practice of Infectious Diseases.  He is currently a member of the Society for Healthcare Epidemiology of America (SHEA) Public Policy and Government Affairs Committee, and in 2005 he chaired the SHEA Task Force on Influenza Vaccination of Healthcare Workers.  As a part of his role as the chief hospital epidemiologist, he oversees the surveillance of nosocomial infections, the development of education for staff and physicians, and the implementation of various quality improvement interventions designed to reduce the incidence of nosocomial infections at Vanderbilt.

 

back to top

 

 

Contact Us Privacy Policy Disclosures